🇺🇸 FDA
Pipeline program

Drug 601

3SGJ601-AMD

Phase 1 small_molecule active

Quick answer

Drug 601 for Wet Age-related Macular Degeneration is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Wet Age-related Macular Degeneration
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials